Shree Ganesh Remedies Limited share price
NSE: SGRL · ISIN INE414Y01015
Key numbers
- Market cap
- ₹ 865 Cr
- Current price
- ₹ 673.75
- 52-week high / low
- ₹ 750 / 490
- Stock P/E
- 56.2
- Book value
- ₹ 127.0
- Dividend yield
- 0.00%
- ROCE
- 14.5%
- ROE
- 11.5%
- Debt to equity
- 0.19
- Sales growth (3 yrs)
- 6.2%
- Profit growth (3 yrs)
- 1.4%
- 1-year return
- -
About Shree Ganesh Remedies Limited
Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally. The company offers anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, antifungal, antihistamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. It also provides fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals. In addition, the company offers customized chemistry and manufacturing; assets and infrastructure; and customized processes of pharmaceutical chemicals. It also exports its products. The company serves life sciences, flavor and fragrance, polymer industries, electronics, and agro chemicals markets. Shree Ganesh Remedies Limited was incorporated in 1995 and is headquartered in Ankleshwar, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 25 | 30 | 21 | 33 | 14 |
| Operating profit | 7 | 10 | 7 | 11 | 3 |
| Net profit | 3 | 5 | 3 | 6 | 1 |
| EPS (₹) | 2.68 | 3.86 | 2.41 | 4.88 | 0.87 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.